Welcome to LookChem.com Sign In|Join Free

CAS

  • or
2,4-Thiazoledicarboxylic acid, 2-ethyl ester is a chemical compound characterized by the molecular formula C6H7NO2S. It presents as a colorless to light yellow liquid with a distinct pungent odor. 2,4-Thiazoledicarboxylic acid,2-ethyl ester is primarily recognized for its role as an intermediate in the synthesis of various products, including pharmaceuticals and agricultural chemicals. Additionally, it contributes to the production of dyes, pigments, and other organic compounds, highlighting its versatility in the chemical industry.

911466-96-1

Post Buying Request

911466-96-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

911466-96-1 Usage

Uses

Used in Pharmaceutical Industry:
2,4-Thiazoledicarboxylic acid, 2-ethyl ester serves as a crucial intermediate in the synthesis of pharmaceuticals. Its chemical structure allows for the development of new drugs, potentially leading to advancements in medicinal chemistry and therapeutic applications.
Used in Agricultural Chemicals:
In the agricultural sector, 2,4-Thiazoledicarboxylic acid,2-ethyl ester is utilized as an intermediate for the production of various agricultural chemicals. Its involvement in this process supports the creation of products that can enhance crop protection and yield.
Used in Dye and Pigment Production:
2,4-Thiazoledicarboxylic acid, 2-ethyl ester is also employed as a chemical intermediate in the manufacturing of dyes and pigments. Its contribution to this industry is essential for the development of a wide range of colorants used in various applications, including textiles, plastics, and printing inks.
Safety and Handling:
Given its potential to cause skin and eye irritation, it is imperative to handle 2,4-Thiazoledicarboxylic acid, 2-ethyl ester with care. Proper safety measures should be adhered to during its storage, use, and disposal to minimize risks to human health and the environment. Compliance with safety regulations is essential to ensure the safe and effective use of this chemical compound in various industries.

Check Digit Verification of cas no

The CAS Registry Mumber 911466-96-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,1,4,6 and 6 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 911466-96:
(8*9)+(7*1)+(6*1)+(5*4)+(4*6)+(3*6)+(2*9)+(1*6)=171
171 % 10 = 1
So 911466-96-1 is a valid CAS Registry Number.

911466-96-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-(Ethoxycarbonyl)thiazole-4-carboxylic acid

1.2 Other means of identification

Product number -
Other names 2-ethoxycarbonyl-1,3-thiazole-4-carboxylic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:911466-96-1 SDS

911466-96-1Relevant articles and documents

NOVEL INDAZOLE COMPOUND OR SALT THEREOF

-

Paragraph 0257, (2021/09/02)

An indazole compound represented by the following Formula (I) or a salt thereof: wherein X, R1, R2, ring A, L1, L2, L3, and R5 are as defined in this specification.

ANTICANCER COMBINATION THERAPY WITH N-(1-ACRYLOYL-AZETIDIN-3-YL)-2-((1H-INDAZOL-3-YL)AMINO)METHYL)-1H-IMIDAZOLE-5-CARBOXAMIDE INHIBITOR OF KRAS-G12C

-

Paragraph 00338, (2021/10/30)

A method of treating cancer comprises administering: (a) a therapeutically effective amount of a compound of Formula (I) or a pharmaceutically acceptable salt thereof; and (b) a therapeutically effective amount of an additional anti-cancer agent, to a subject in need of such treatment, the compound of Formula (I) being: where X, R1, R2, ring A, L1, L2, L3, and R5 are as defined in this disclosure.

METHODS OF TREATING CANCER

-

Paragraph 00429, (2020/06/10)

The present disclosure relates to methods of treating cancer in a patient using a combination of an inhibitor of an immune checkpoint protein and an indole compound or its phosphate derivative.

INDOLE COMPOUNDS AND THEIR USE

-

Paragraph 00191; 00367; 00368, (2019/06/05)

The present disclosure relates to indole compounds and pharmaceutical compositions thereof, and their use in stimulating the immune system of patients in need thereof and in treating cancer.

NOVEL FERROPORTIN INHIBITORS

-

Page/Page column 258, (2017/05/10)

The invention relates to novel ferroportin inhibitors of the general formula (I) pharmaceutical compositions comprising them and the use thereof as medicaments, in particular for the prophylaxis and/or treatment of diseases caused by a lack of hepcidin or iron metabolism disorders, such as particularly iron overload states such as in particular thalassemia and hemochromatosis.

6-AMINOPYRIDIN-3-YL THIAZOLES AS MODULATORS OF RORyT

-

Paragraph 0483-0485, (2017/11/16)

The present invention comprises compounds of Formula I. wherein: A1, A2, A3, A4, A5, R1, and R2 are defined in the specification. The invention also comprises a method of treating or ameliorating a syndrome, disorder or disease, wherein the syndrome, disorder or disease is rheumatoid arthritis or psoriasis. The invention also comprises a method of modulating RORγt activity in a mammal by administration of a therapeutically effective amount of at least one compound of Formula I.

Design and synthesis of thiazole and thiazolidine metallo-supramolecular networks

Di Credico, Barbara,Gonsalvi, Luca,Peruzzini, Maurizio,Reginato, Gianna,Rossin, Andrea

scheme or table, p. 1312 - 1315 (2011/09/15)

A mild and selective procedure for the synthesis of 4-carboxy thiazoles and thiazolidines starting from naturally occurring cysteine by condensation with aldehydes is described. The optimized procedure, taking advantage of the positive effect of microwave

DIAMIDO THIAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS

-

Page/Page column 54, (2009/06/27)

The present invention relates to novel Diamido Thiazole Derivatives of structure I, compositions comprising the Diamido Thiazole Derivatives, and methods for using the Diamido Thiazole Derivatives for treating or preventing a proliferative disorder, an anti -proliferative disorder, inflammation, arthritis, a central nervous system disorder, a cardiovascular disease, alopecia, a neuronal disease, an ischemic injury, a viral infection, a fungal infection, or a disorder related to the activity of a protein kinase. Formula (I) wherein: M is -C(O)-, -C(S)-. -S(O)-. -S(O)2-. -NHS(O)2-. -OC(O)- or -NHC(O)-; Q is:formula (II).

ANILINOPIPERAZINE DERIVATIVES AND METHODS OF USE THEREOF

-

Page/Page column 134-135, (2008/12/05)

The present invention relates to novel Anilinopiperazine Derivatives of Formula (I), compositions comprising the Anilinopiperazine Derivatives, and methods for using the Anilinopiperazine Derivatives for treating or preventing a proliferative disorder, cancer, an anti-proliferative disorder, inflammation, arthritis, a central nervous system disorder, a cardiovascular disease, alopecia, a neuronal disease, an ischemic injury, a viral disease, a fungal infection, or a disorder related to the activity of a protein kinase.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 911466-96-1